<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05032768</url>
  </required_header>
  <id_info>
    <org_study_id>FDRT-BC015</org_study_id>
    <nct_id>NCT05032768</nct_id>
  </id_info>
  <brief_title>The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients</brief_title>
  <official_title>The Association Between Radiation Dermatitis and Skin Microbiome in Breast Cancer Patients Receiving Radiation After Mastectomy and Reconstructive Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fudan University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The breast cancer patients who received radiotherapy after mastectomy and breast&#xD;
      reconstruction will be enrolled. The skin microbiome before radiotherapy and its changes&#xD;
      after radiotherapy will be analyzed systematically to find out whether the skin microbiome is&#xD;
      associated with the severity of radiation dermatitis.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Radiotherapy is an important treatment for breast cancer patients. About 95% of patients&#xD;
      receiving radiotherapy will develop a degree of radiation dermatitis. Radiation dermatitis is&#xD;
      usually limited to the site of radiation treatment. Symptoms vary and can range from itching,&#xD;
      burning and pain to open or bleeding ulcers, which can greatly affect the quality of life of&#xD;
      patients. Severe acute radiation dermatitis can lead to interruption or delay of treatment.&#xD;
      At present, there is no standard for the prevention and treatment of radiation dermatitis.&#xD;
      Our skin is home to millions of bacteria, fungi and viruses which compose the skin&#xD;
      microbiota. Skin microbiota interacts with skin and affects physiology and immunity of the&#xD;
      skin. Previous studies have reported the effects of radiotherapy on skin and immune system.&#xD;
      However, so far, no studies have analyzed the effects of radiotherapy on skin microbiome and&#xD;
      how skin microbiome affects the skin immune responses after radiotherapy. In this study, the&#xD;
      breast cancer patients who received radiotherapy after mastectomy and breast reconstruction&#xD;
      will be enrolled. The skin microbiome before radiotherapy and its changes after radiotherapy&#xD;
      will be analyzed systematically to find out whether the skin microbiome is associated with&#xD;
      the severity of radiation dermatitis. The long-term goal of this study is to deepen the&#xD;
      understanding of the role of skin microbiome in the occurrence and development of radiation&#xD;
      dermatitis, and provide a basis for subsequent exploration to reduce radiation dermatitis by&#xD;
      regulating skin microecology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Skin microbiome differences between patients with and without &gt;=2 acute radiation dermatitis</measure>
    <time_frame>3 months</time_frame>
    <description>Acute radiation dermatitis will be graded per the Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Skin microbiome differences between patients with and without &gt;=2 late radiation dermatitis</measure>
    <time_frame>5 years</time_frame>
    <description>Late radiation dermatitis will be graded per the Toxicity Criteria of the Radiation Therapy Oncology Group (RTOG)</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Radiation Dermatitis</condition>
  <condition>Skin Microbiome</condition>
  <condition>Breast Cancer</condition>
  <condition>Reconstructive Surgery</condition>
  <arm_group>
    <arm_group_label>Severe radiation dermatitis</arm_group_label>
    <description>RTOG/EORTC grade 2 and above</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No or mild radiation dermatitis</arm_group_label>
    <description>RTOG/EORTC grade 0 or 1</description>
  </arm_group>
  <intervention>
    <intervention_type>Radiation</intervention_type>
    <intervention_name>post-operative radiotherapy</intervention_name>
    <description>Breast cancer patients who have received reconstructive surgery will receive post-operative radiotherapy.</description>
    <arm_group_label>No or mild radiation dermatitis</arm_group_label>
    <arm_group_label>Severe radiation dermatitis</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      The skin microbiome will be collected and analyzed. Bacteria 16S rRNA amplicon sequencing and&#xD;
      fungal rRNA its (internal transcribed spacer) sequencing will be used to analyze skin&#xD;
      microorganisms (including bacteria and fungi)&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Breast cancer patients who have underwent mastectomy and breast reconstruction and who will&#xD;
        receive post-operative radiotherapy.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Female patients&#xD;
&#xD;
          2. Invasive breast cancer confirmed by pathology&#xD;
&#xD;
          3. Underwent mastectomy and breast reconstruction&#xD;
&#xD;
          4. Radiotherapy after breast reconstruction&#xD;
&#xD;
          5. ECOG score 0-1&#xD;
&#xD;
          6. Signed informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Previous breast or chest radiotherapy&#xD;
&#xD;
          2. Other serious skin diseases (systemic lupus erythematosus, skin sclerosis, et al) and&#xD;
             cannot receive radiotherapy&#xD;
&#xD;
          3. Pregnant women&#xD;
&#xD;
          4. Patients who are unwilling or unable to receive regular follow-up.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Xiaoli Yu, MD, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Fudan University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Wei Shi, MD, Ph.D</last_name>
    <phone>+86 18121299680</phone>
    <email>wei.shi118@foxmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Li Zhang, MD</last_name>
    <email>zhangliaaa111@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Fudan University Shanghai Cancer Center</name>
      <address>
        <city>Shanghai</city>
        <state>Shanghai</state>
        <zip>200032</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>July 25, 2021</study_first_submitted>
  <study_first_submitted_qc>September 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 2, 2021</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
    <mesh_term>Dermatitis</mesh_term>
    <mesh_term>Radiodermatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

